{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:09:47Z","timestamp":1774552187446,"version":"3.50.1"},"reference-count":40,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Econom\u00eda, Industria y Competitividad, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["BFU2012-39151 and BFU2015-71371-R"],"award-info":[{"award-number":["BFU2012-39151 and BFU2015-71371-R"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Catalysis","award":["CT-001"],"award-info":[{"award-number":["CT-001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Nutritional supplements which include natural antitumoral compounds could represent safe and efficient additives for cancer patients. One such nutritional supplement, Ocoxin Oral solution (OOS), is a composite formulation that contains several antioxidants and exhibits antitumoral properties in several in vitro and in vivo tumor conditions. Here, we performed a functional genomic analysis to uncover the mechanism of the antitumoral action of OOS. Using in vivo models of acute myelogenous leukemia (AML, HEL cells, representative of a liquid tumor) and small-cell lung cancer (GLC-8, representative of a solid tumor), we showed that OOS treatment altered the transcriptome of xenografted tumors created by subcutaneously implanting these cells. Functional transcriptomic studies pointed to a cell cycle deregulation after OOS treatment. The main pathway responsible for this deregulation was the E2F\u2013TFDP route, which was affected at different points. The alterations ultimately led to a decrease in pathway activation. Moreover, when OOS-deregulated genes in the AML context were analyzed in patient samples, a clear correlation with their levels and prognosis was observed. Together, these data led us to suggest that the antitumoral effect of OOS is due to blockade of cell cycle progression mainly caused by the action of OOS on the E2F\u2013TFDP pathway.<\/jats:p>","DOI":"10.3390\/nu11051068","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T10:42:33Z","timestamp":1557830553000},"page":"1068","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5405-5494","authenticated-orcid":false,"given":"Javier","family":"P\u00e9rez-Pe\u00f1a","sequence":"first","affiliation":[{"name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC and CIBERONC, 37007 Salamanca, Spain"},{"name":"Centro Regional de Investigaciones Biom\u00e9dicas, Universidad de Castilla La Mancha, 02008 Albacete, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"D\u00edaz-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC and CIBERONC, 37007 Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Sanz","sequence":"additional","affiliation":[{"name":"Research and Development, Catalysis S.L., 28016 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atanasio","family":"Pandiella","sequence":"additional","affiliation":[{"name":"Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, CSIC and CIBERONC, 37007 Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3389\/fpls.2015.00799","article-title":"Plant derived substances with anti-cancer activity: From folklore to practice","volume":"6","author":"Fridlender","year":"2015","journal-title":"Front Plant Sci."},{"key":"ref_2","first-page":"4103","article-title":"Medicinal Plants: Their Use in Anticancer Treatment","volume":"6","author":"Greenwell","year":"2015","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"ref_3","first-page":"1231","article-title":"Vinca alkaloids","volume":"4","author":"Moudi","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1535-7163.MCT-13-0791","article-title":"Targeting microtubules by natural agents for cancer therapy","volume":"13","author":"Mukhtar","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/j.1552-4604.1990.tb01873.x","article-title":"New natural products in cancer chemotherapy","volume":"30","author":"Slichenmyer","year":"1990","journal-title":"J. Clin. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00001813-199112000-00002","article-title":"Taxol: A new and effective anti-cancer drug","volume":"2","author":"Slichenmyer","year":"1991","journal-title":"Anticancer Drugs"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lichota, A., and Gwozdzinski, K. (2018). Anticancer Activity of Natural Compounds from Plant and Marine Environment. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113533"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4103\/0019-509X.176699","article-title":"Increased survival of patients with end-stage hepatocellular carcinoma due to intake of ONCOXIN((R)), a dietary supplement","volume":"52","author":"Akbar","year":"2015","journal-title":"Indian J. Cancer"},{"key":"ref_9","first-page":"172","article-title":"Findings of the 3-Month supportive treatment with ocoxin solution beside the standard modalities of patients with different neoplastic diseases","volume":"22","author":"Mahmood","year":"2009","journal-title":"TAJ"},{"key":"ref_10","first-page":"198","article-title":"Tea flavonols in cardiovascular disease and cancer epidemiology","volume":"220","author":"Hollman","year":"1999","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ijc.2910620319","article-title":"Cinnamic acid: A natural product with potential use in cancer intervention","volume":"62","author":"Liu","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"472S","DOI":"10.1093\/jn\/130.2.472S","article-title":"Tea and tea polyphenols in cancer prevention","volume":"130","author":"Yang","year":"2000","journal-title":"J. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sankaranarayanan, R., Valiveti, C.K., Kumar, D.R., Van Slambrouck, S., Kesharwani, S.S., Seefeldt, T., Scaria, J., Tummala, H., and Bhat, G.J. (2019). The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention. Cancers, 11.","DOI":"10.3390\/cancers11030427"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.3748\/wjg.v16.i21.2638","article-title":"Antioxidant and immunomodulatory effects of Viusid in patients with chronic hepatitis C","volume":"16","author":"Gomez","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1080\/01635581.2015.1068819","article-title":"Effect of Oncoxin Oral Solution in HER2-Overexpressing Breast Cancer","volume":"67","author":"Gonzalez","year":"2015","journal-title":"Nutr. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3892\/ol.2017.6016","article-title":"Ocoxin oral solution((R)) as a complement to irinotecan chemotherapy in the metastatic progression of colorectal cancer to the liver","volume":"13","author":"Benedicto","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3892\/or.2015.4486","article-title":"Ocoxin(R) oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb\/c mice","volume":"35","author":"Marquez","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3892\/ol.2017.6440","article-title":"Antitumoral effect of Ocoxin in hepatocellular carcinoma","volume":"14","author":"Sanz","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_19","first-page":"113","article-title":"Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer","volume":"53","author":"Sanz","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6231","DOI":"10.18632\/oncotarget.6862","article-title":"Antitumoral effect of Ocoxin on acute myeloid leukemia","volume":"7","author":"Sanz","year":"2016","journal-title":"Oncotarget"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Diaz-Rodriguez, E., Perez-Pena, J., Rios-Luci, C., Arribas, J., Ocana, A., and Pandiella, A. (2019). TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells. Cancer Lett.","DOI":"10.1016\/j.canlet.2019.03.042"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/bioinformatics\/btl565","article-title":"Predicting transcription factor affinities to DNA from a biophysical model","volume":"23","author":"Roider","year":"2007","journal-title":"Bioinformatics"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"D674","DOI":"10.1093\/nar\/gkn653","article-title":"PID: The Pathway Interaction Database","volume":"37","author":"Schaefer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1101\/gad.12.15.2245","article-title":"The regulation of E2F by pRB-family proteins","volume":"12","author":"Dyson","year":"1998","journal-title":"Genes Dev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1101\/gad.813200","article-title":"The Rb\/E2F pathway: Expanding roles and emerging paradigms","volume":"14","author":"Harbour","year":"2000","journal-title":"Genes Dev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrm714","article-title":"Sibling rivalry in the E2F family","volume":"3","author":"Trimarchi","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/tcr.20039","article-title":"Green tea: Health benefits as cancer preventive for humans","volume":"5","author":"Fujiki","year":"2005","journal-title":"Chem. Rec."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.21873\/anticanres.11409","article-title":"Treatment of Hematological Malignancies with Glycyrrhizic Acid","volume":"37","author":"Hostetler","year":"2017","journal-title":"Anticancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/13880209.2011.559476","article-title":"Inhibition of tumor progression by naturally occurring terpenoids","volume":"49","author":"Kuttan","year":"2011","journal-title":"Pharm. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phrs.2005.02.011","article-title":"Mediation of cell death by poly(ADP-ribose) polymerase-1","volume":"52","author":"Koh","year":"2005","journal-title":"Pharmacol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4615-4811-9_24","article-title":"Apoptosis. Molecules and mechanisms","volume":"457","author":"Konopleva","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1023\/A:1016119328968","article-title":"Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: An update","volume":"7","author":"Soldani","year":"2002","journal-title":"Apoptosis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/o97-043","article-title":"Cleavage of poly(ADP-ribose) polymerase: A sensitive parameter to study cell death","volume":"75","author":"Duriez","year":"1997","journal-title":"Biochem. Cell Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4939-2957-3_4","article-title":"E2F Transcription Factors Control the Roller Coaster Ride of Cell Cycle Gene Expression","volume":"1342","author":"Thurlings","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: An exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/nrc950","article-title":"The retinoblastoma tumour suppressor in development and cancer","volume":"2","author":"Classon","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc2401","article-title":"Tailoring to RB: Tumour suppressor status and therapeutic response","volume":"8","author":"Knudsen","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.leukres.2018.12.014","article-title":"Involvement of pRb-E2F pathway in green tea extract-induced growth inhibition of human myeloid leukemia cells","volume":"77","author":"Henry","year":"2019","journal-title":"Leuk. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3892\/ijo.2015.2819","article-title":"Glycyrrhetinic acid induces G1phase cell cycle arrest in human nonsmall cell lung cancer cells through endoplasmic reticulum stress pathway","volume":"46","author":"Zhu","year":"2015","journal-title":"Int. J. Oncol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/11\/5\/1068\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:51:40Z","timestamp":1760187100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/11\/5\/1068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["nu11051068"],"URL":"https:\/\/doi.org\/10.3390\/nu11051068","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]}}}